Lidocaine
NDC Package 55910-840-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lidocaine is a medication used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). Marketed by Dolgencorp, Inc. (dollar General & Rexall), this product is identified by NDC 55910-840 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
55910-840-45
Package Description
127 g in 1 CAN
Product Code
55910-840
11-Digit Billing Format
55910084045

Clinical Specifications

Proprietary Name
Lidocaine
Dosage Form
-
Usage Information
This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

Regulatory & Marketing

Labeler Name
Dolgencorp, Inc. (dollar General & Rexall)
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-08-2017
End Marketing Date
05-08-2019
Listing Expiration
05-08-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55910-840-45 identifies a specific commercial package of 127 g in 1 can of Lidocaine, labeled by Dolgencorp, Inc. (dollar General & Rexall). This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dolgencorp, Inc. (dollar General & Rexall) on May 08, 2017. The current certification is valid through May 08, 2019.

What are the primary indications for this medication?

This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

How is this Dolgencorp, Inc. (dollar General & Rexall) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910084045. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55910-840-45
11-Digit CMS (5-4-2)
55910-0840-45

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.